July 15  2005 Murray  Clinton Declare Victory in Fight Over Plan B                                                                                                                                                                                                                                                                                                                                                             Decision On Over The Counter Sales Of Emergency Contraceptives Will Be Made By September 1                                                                                                                                                                                                                                                                                                                       Washington  DC    U S  Senators Patty Murray  D WA  and Hillary Rodham Clinton  D NY  today announced victory in their efforts to force the FDA to make a decision regarding the over the counter application of Plan B emergency contraceptives   The Senators issued the following statement on the news from Secretary of Health and Human Services Michael O  Leavitt that the FDA will act on Plan B  s application by September 1  2005           It is long past time that the American people had a decision on Plan B and the FDA has finally agreed to give women across the country what we have fought for from the beginning    a yes or no decision   After more than two years of waiting  American consumers and American women will finally get an answer         While we continue to have concerns about the lack of leadership and independent decision making that Dr  Crawford and the FDA have shown in this case  we have been clear all along that our hold on this nomination is about one thing only  the FDA  s failure to provide an answer on Plan B          As we have now received a date for a decision on Plan B  we have agreed to release our hold on Dr  Crawford  s nomination          We will continue to closely monitor the actions of the FDA to ensure that American patients receive access to safe and effective treatments in a timely manner               